Vaxart, Inc. Business Combination, Bargain Purchase, Gain Recognized, Amount
Vaxart, Inc. (VXRT) reported Business Combination, Bargain Purchase, Gain Recognized, Amount of $6.76 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Other Income
us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount · last filed 2021-02-25
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for the quarter ending 2018-12-31 was $100.00K.
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for the quarter ending 2018-09-30 was $0.00.
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for the quarter ending 2018-06-30 was -$328.00K.
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for the quarter ending 2018-03-31 was $6.99M.
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for fiscal 2018 was $6.76M.
- Vaxart, Inc. business combination, bargain purchase, gain recognized, amount for fiscal 2013 was $7.80M.
| Period end | Business Combination, Bargain Purchase, Gain Recognized, Amount | Business Combination, Bargain Purchase, Gain Recognized, Amount 0 month | Business Combination, Bargain Purchase, Gain Recognized, Amount 3 month | Business Combination, Bargain Purchase, Gain Recognized, Amount 6 month | Business Combination, Bargain Purchase, Gain Recognized, Amount 9 month | Business Combination, Bargain Purchase, Gain Recognized, Amount 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $100.00K derived: sum of 2 quarters · filed 2021-02-25 | -$228.00K derived: sum of 3 quarters · filed 2021-02-25 | $6.76M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$328.00K derived: sum of 2 quarters · filed 2019-11-12 | $6.66M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$328.00K 10-Q · filed 2018-08-10 | $6.66M 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | $6.99M 10-Q · filed 2019-05-09 | |||||
| 2018-02-13 | $6.99M 10-Q · filed 2018-05-15 | |||||
| 2013-06-30 | $7.80M 10-K · filed 2013-09-27 | |||||
| 2012-12-31 | $7.80M 10-Q · filed 2013-02-11 | |||||
| 2012-11-08 | $7.80M 10-Q · filed 2014-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |